Appendicitis Market Share

Global Appendicitis Market Overview

Appendicitis Market Size was valued at USD 7.1 Billion in 2022. The Appendicitis market industry is projected to grow from USD 7.39 Billion in 2023 to USD 10.19 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.10% during the forecast period (2023 - 2032). Appendicitis cases are rising, and illness awareness is rising are the key market drivers enhancing the market growth.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

In March 2024, Carlos Sainz Jr is expected to return for Ferrari at this weekend’s Australian Grand Prix after having his appendix removed via surgery. He was withdrawn from competition after complaining that he felt unwell during practice at the Saudi Arabian GP last time out, leading to Ferrari calling up Oliver Bearman for his Formula One debut just ahead of qualifying. Verstappen won again on Sunday ahead of Perez as Leclerc collected another third-place finish.

According to the final results of the Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) trial presented at the American College of Surgeons (ACS) virtual Clinical Congress 2021 and published online in New England Journal of Medicine.

In November 2023- The MONARCH Bronchoscopy Platform was granted a regulatory license in China.

In October 2023- PENBRAYATM is the only vaccine that has been approved by the Food and Drug Administration to protect against the five most common serogroups responsible for adolescent meningococcal disease.

Appendicitis Market Trends

• Growing awareness is driving the market growth

Market CAGR for appendicitis is being driven by the rising awareness among people. With a mean age of 28, appendicitis mostly affects people between the ages of 5 and 45. Accordingly, the incidence is roughly 233/100,000 persons. Compared to chronic appendicitis, acute appendicitis is more common. Acute appendicitis affects one in every fifteen persons at some point. In the United States, appendectomies are performed more than 250,000 times annually, yet people that consume a high-fiber diet have a reduced incidence of the procedure. The combined incidence of appendicitis or appendectomy worldwide is approximately 100 per 100,000 person-years. Children with cystic fibrosis may develop pediatric appendicitis, which has a higher risk. A family history of the disease may also increase a child's chance of developing appendicitis. The minimally invasive Transumbilical Laparoscopic Assisted Appendicectomy procedure can be used to diagnose it. Although it has not yet become the gold standard, laparoscopic-assisted single-port appendectomy (SPA) has been done on children and has been deemed safe. Imaging is helpful in uncertain circumstances, such as female patients of childbearing age, as appendicitis is thought to be a clinical diagnosis in these situations. Many pieces of equipment are used to diagnose appendicitis, such as ultrasound, which is becoming popular, especially in children who are most at risk from ionizing radiation. The benefits include lower costs than other imaging techniques and no exposure to ionizing radiation. C.T. of the abdomen and pelvis is also regarded as the preferred modality for final assessing patients who have been screened for potential appendicitis. The  market for appendicitis diagnostics and treatment will grow as appendicitis cases rise.

The high  prevalence of appendicitis is a key factor driving the market. Although appendicitis is a common ailment worldwide and more common in wealthy economies, it is becoming more common in emerging nations. Due to their diets' inclusion of dietary fibers, which reduces the incidence of appendicitis, African countries have less acute appendicitis. The rising prevalence of pediatric appendicitis is a significant driver of the appendicitis industry.

Other factors boosting the growth of the appendicitis market ly include awareness and quicker adoption of diagnostic procedures for the condition. Compared to emerging economies, these approaches are more prevalent in established economies like the U.S. and Europe. However, increasing knowledge of the many appendicitis diagnostic tests is anticipated to promote their use in developing nations in Asia and Latin America. Another element fueling the need for surgery for the appendix issue is minimally invasive procedures. The diagnosis of appendicitis using blood biomarkers has yielded promising results. Thus, driving the Appendicitis market revenue.

Appendicitis Market Segment Insights

Appendicitis Type Insights

The  Appendicitis market segmentation, based on type, includes acute and chronic. The acute segment dominated the market, accounting for 68% of market revenue. Acute appendicitis is a common surgical emergency diagnosed by combining a clinical picture with the history, examination, and investigations. Acute appendicitis has typically been treated with an appendectomy. There are numerous described diagnostic scoring systems for acute appendicitis.

Appendicitis Diagnosis & Treatment Insights

The  Appendicitis market segmentation, based on diagnosis & treatment, includes diagnosis {ultra sound imaging, Ct Scan, others}, treatment {medication, surgery, others}). The treatment segment dominated the market. Surgery to remove the inflamed appendix is typically part of the therapy for appendicitis. The procedure used to remove the appendix is called an appendectomy. It is the accepted course of action for practically all appendicitis patients. One of the following techniques, such as laparoscopic surgery or a laparotomy, is used to operate. In laparoscopic surgery, the appendix is removed using a series of tiny incisions and specialized surgical equipment fed via the incisions. Laparoscopic surgery has a quicker recovery period and causes fewer complications, such as infections acquired in the hospital. While a laparotomy only requires a single incision in the lower right corner of your belly to remove the appendix. Surgery, including laparoscopy, is most frequently chosen for less invasive treatments.

Appendicitis End User Insights

The  Appendicitis market segmentation, based on end users, includes hospitals & clinics, and diagnostic centers. The diagnostic centers generated the most income (70.4%). Tests are required to confirm the diagnosis and rule out other illnesses if the symptoms of appendicitis are not typical. The diagnosis of appendicitis can now be made using a variety of diagnostic procedures. An imaging test is the best way to determine whether you have appendicitis or another type of abdominal pain. To create an image of the anatomy of your organs during an abdominal ultrasound, the doctor uses a transducer to bounce safe, painless sound waves off of your organs. A radiologist examines the images and may reveal indications of an appendiceal lumen obstruction, an appendix rupture, inflammation, or other causes of stomach pain.

Figure 1  Appendicitis Market, by End User, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Appendicitis Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Appendicitis market area will dominate this market because there is a greater need for good treatment as appendicitis is becoming more common, more people are aware of it, and it is more common. The US spends more on healthcare than in previous years, which could cause the medical device business to grow more quickly.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  APPENDICITIS MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Appendicitis market accounts for the second-largest market share. The region's appendicitis market is expanding due to ongoing research in molecular diagnostic technologies and the increased occurrence of infectious diseases. Further, the German Appendicitis market held the largest market share, and the UK Appendicitis market was the fastest-growing market in the European region.

The Asia-Pacific Appendicitis Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the rise in outpatient venues offering imaging services and their focus on forming partnerships to improve imaging services and patient care. Moreover, China's Appendicitis market held the largest market share, and the Indian Appendicitis market was the fastest-growing market in the Asia-Pacific region.

Appendicitis Key Market Players & Competitive Insights

Leading industry companies are making significant R&D investments to diversify their product offerings, which will drive the Appendicitis market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants also engage in several strategic actions to increase their worldwide presence. The Appendicitis industry must provide affordable products to grow and thrive in a more competitive and challenging market environment.

Local manufacturing to cut operating costs is one of the key business tactics manufacturers use in the  Appendicitis industry to help clients and expand the market sector. The Appendicitis industry has offered some of the most significant advantages in recent years. Major players in the Appendicitis market, including B. Braun, and others, are attempting to increase market demand by investing in research and development operations.

• Braun is one of the top producers and suppliers of healthcare products worldwide. Every service that B. Braun offers draws on all of our knowledge and expertise and the company's significant experience and deep understanding of user demands spanning more than 180 years. B. Braun works to safeguard and enhance people's health with its ever-expanding line of suitable medical care products. Five thousand different products make up the B. Braun product line, 95% of which are made by the business. Additionally, B. Braun is a system provider that works closely with its clients to produce the optimum solution for patients, significantly advancing medical science. This is done by providing supplemental services and consultation.

An American manufacturer of medical equipment is Medtronic plc. Due to its 2015 acquisition of the Irish-based Covidien, the business has its operational and executive offices in Minneapolis, Minnesota, and its legal headquarters in Ireland. Although it works largely in the United States, it also does so in more than 150 other nations. The Diabetes Group, the Restorative Therapies Group, the Cardiac and Vascular Group, and the Minimally Invasive Therapies Group are Medtronic's four primary business divisions. More than 30 chronic diseases, including Parkinson's disease,  spinal abnormalities, heart failure, urine incontinence, obesity, Down syndrome, chronic pain, and diabetes, are treated by the devices and therapies that Medtronic develops and produces.

Key Companies in the Appendicitis market include

• Johnson & Johnson Services Inc (US)


• Pfizer Inc (US)


• Lupin (India)


• Siemens (Germany)


• Koninklijke Philips NV (Netherlands)


• Becton, Dickinson and Company (US)


• Braun Melsungen AG (Germany)


• Cook (US)


• Medtronic (Ireland)


• Teva Pharmaceutical Industries Ltd (Israel).

Appendicitis Industry Developments

October 2020 With a focus on veterans, minorities, and other underrepresented areas, B. Braun Medical Inc. (B. Braun) and Kerma Medical Products, Inc. (Kerma) announced a collaboration to improve the development and delivery of healthcare products and services. The businesses will collaborate on various projects, such as product development, co-marketing chances, strategic sourcing, sustainable manufacturing, and diversity initiatives.

Appendicitis Market Segmentation

Appendicitis Type Outlook

• Acute


• Chronic

Appendicitis Diagnosis & Treatment Outlook

• Diagnosis


• Ultra Sound Imaging


• Ct Scan


• Others


• Treatment


• Medication


• Surgery


• Others

Appendicitis End User Outlook

• Hospitals & Clinics


• Diagnostic Centers

Appendicitis Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America